US Patent Issued to Brii Biosciences on March 25 for "Combination therapy for HIV with adenosine derivative and capsid inhibitors" (North Carolina Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,264, issued on March 25, was assigned to Brii Biosciences Inc. (Durham, N.C.).

"Combination therapy for HIV with adenosine derivative and capsid inhibitors" was invented by Lianhong Xu (Durham, N.C.) and Zhi Hong (Durham, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to methods of treating or preventing RNA virus infections and retroviral diseases, such as HIV and AIDS, comprising administering to a subject in need an effective amount of (a) a capsid inhibitor and (b) an adenosine derivative disclosed herein. Compositions comprising an effective amount of an adenosine derivative and an effective amount of a ...